These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34720162)

  • 21. An investigation of the effects of procalcitonin testing on antimicrobial prescribing in respiratory tract infections in an Irish university hospital setting: a feasibility study.
    O'Riordan F; Shiely F; Byrne S; O'Brien D; Palmer B; Dahly D; O'Connor TM; Curran D; Fleming A
    J Antimicrob Chemother; 2019 Nov; 74(11):3352-3361. PubMed ID: 31325313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission--a randomized trial.
    Kristoffersen KB; Søgaard OS; Wejse C; Black FT; Greve T; Tarp B; Storgaard M; Sodemann M
    Clin Microbiol Infect; 2009 May; 15(5):481-7. PubMed ID: 19416298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Procalcitonin-guided Antibiotics in Respiratory Infections (PARI) project in general practice - a study protocol.
    Filipsen N; Bro H; Bjerrum L; Jensen JS; Aabenhus R
    BMC Prim Care; 2022 Mar; 23(1):43. PubMed ID: 35279069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A health economic model analysis.
    Mewes JC; Pulia MS; Mansour MK; Broyles MR; Nguyen HB; Steuten LM
    PLoS One; 2019; 14(4):e0214222. PubMed ID: 31013271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance.
    Dusemund F; Bucher B; Meyer S; Thomann R; Kühn F; Bassetti S; Sprenger M; Baechli E; Sigrist T; Schwietert M; Amin D; Hausfater P; Carre E; Schuetz P; Gaillat J; Regez K; Bossart R; Schild U; Müller B; Albrich WC;
    Eur J Clin Microbiol Infect Dis; 2013 Jan; 32(1):51-60. PubMed ID: 22886090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of Procalcitonin-Guided Antibiotic Therapy in Lower Respiratory Tract Infections.
    Drozdov D; Dusemund F; Müller B; Albrich WC
    Antibiotics (Basel); 2013 Jan; 2(1):1-10. PubMed ID: 27029288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Collaborative Approach to Improve Consistent Use of Procalcitonin in Lower Respiratory Tract Infections.
    Levine AR; Riggott R; Vulaj K; Falcetti TR; Ali S; Singh G
    Ann Pharmacother; 2018 Jun; 52(6):538-545. PubMed ID: 29322872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Pharmacist-Led Procalcitonin-Guided Antibiotic Therapy in Critically Ill Patients With Pneumonia.
    Subedi B; Louzon P; Zappas K; Onyia W; DeBoer K
    Hosp Pharm; 2020 Jun; 55(3):204-210. PubMed ID: 32508359
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
    Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
    JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Procalcitonin to guide antibiotic decision making.
    Branche A; Neeser O; Mueller B; Schuetz P
    Curr Opin Infect Dis; 2019 Apr; 32(2):130-135. PubMed ID: 30648993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of serum procalcitonin for the guidance of antibiotic therapy in children with lower respiratory tract infection].
    Dai BQ; Yuan XT; Liu JM
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Dec; 17(12):1292-6. PubMed ID: 26695667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to: implement procalcitonin testing in my practice.
    Neeser O; Branche A; Mueller B; Schuetz P
    Clin Microbiol Infect; 2019 Oct; 25(10):1226-1230. PubMed ID: 30616016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ProCommunity: procalcitonin use in real-world US community hospital settings.
    DeSear KE; Thompson-Leduc P; Kirson N; Chritton JJ; Ie S; Van Schooneveld TC; Cheung HC; Ou S; Schuetz P
    Curr Med Res Opin; 2020 Sep; 36(9):1529-1532. PubMed ID: 32643964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
    Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
    Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Procalcitonin-Guided Antibiotic Management on Antibiotic Exposure and Outcomes: Real-world Evidence.
    Broyles MR
    Open Forum Infect Dis; 2017; 4(4):ofx213. PubMed ID: 29164170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations.
    Bremmer DN; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Walsh TL
    J Gen Intern Med; 2018 May; 33(5):692-697. PubMed ID: 29404940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Procalcitonin Measurement and Viral Testing to Guide Antibiotic Use for Respiratory Infections in Hospitalized Adults: A Randomized Controlled Trial.
    Branche AR; Walsh EE; Vargas R; Hulbert B; Formica MA; Baran A; Peterson DR; Falsey AR
    J Infect Dis; 2015 Dec; 212(11):1692-700. PubMed ID: 25910632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis.
    Peng F; Chang W; Xie JF; Sun Q; Qiu HB; Yang Y
    Int J Infect Dis; 2019 Aug; 85():158-166. PubMed ID: 31229612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy.
    Creamer AW; Kent AE; Albur M
    Breathe (Sheff); 2019 Dec; 15(4):296-304. PubMed ID: 31803264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.